The hemodialysis market size has grown steadily in recent years. It will grow from $91.91 billion in 2024 to $96.28 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to the rising incidence of chronic kidney disease (CKD), growing awareness of renal health, government initiatives for renal care, global expansion of dialysis centers, and lifestyle-related factors.
The hemodialysis market size is expected to see strong growth in the next few years. It will grow to $125.15 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing healthcare expenditure, telehealth integration in renal care, regulatory support for home hemodialysis, focus on personalized medicine in nephrology, and global health crisis preparedness. Major trends in the forecast period include minimally invasive procedures, technological advancements, patient-friendly devices, integration with imaging and diagnostics, and customized treatment approaches.
The rising incidence of kidney failure is expected to drive the growth of the hemodialysis market in the coming years. Kidney failure is a medical condition characterized by the kidneys' inability to effectively filter waste and excess fluids from the blood. The increase in kidney failure cases is largely attributed to the growing rates of chronic conditions such as diabetes and hypertension, coupled with an aging population and lifestyle factors. Patients with kidney failure rely on hemodialysis to artificially filter and eliminate waste, excess fluids, and toxins from their blood through a machine, compensating for the reduced function of their kidneys. For example, a report published in June 2023 by Nephrology Dialysis Transplantation (NDT), a UK-based journal, projected that the number of individuals with Chronic Kidney Disease (CKD) in the UK will increase by 4% between 2022 and 2032, rising from 8.27 million to 8.61 million. Thus, the growing prevalence of kidney failure is set to boost the hemodialysis market.
The growth of the hemodialysis market is also influenced by the increasing incidence of lifestyle-related diseases, particularly obesity. Lifestyle-related diseases significantly impact an individual's health, playing a pivotal role in the development of chronic kidney disease (CKD), necessitating hemodialysis. The World Health Organization reported in March 2022 that over 1 billion people globally, including 650 million adults, 340 million teenagers, and 39 million children, suffer from obesity, a number continually rising. With lifestyle-related diseases contributing to CKD, the demand for hemodialysis is expected to grow significantly.
The technological advancements are a notable trend, with major companies concentrating on innovative technologies to maintain their market positions. In August 2022, Fresenius Medical Care AG & Co. KGaA introduced Speedswap, an innovative option for the NxStage System One with NxView. This technology allows changing a flow-compromised dialysis filter without replacing the entire cartridge, reducing therapy downtime, nursing workloads, and treatment costs in acute care settings. Technological innovation enhances patient care and operational efficiency in the hemodialysis sector.
A strategic partnership approach is adopted by major companies operating in the hemodialysis market to enhance patient outcomes and treatment experiences. In May 2022, Medtronic Plc announced a partnership with DaVita Inc. to establish a novel, independent medical device business called NewCo, focusing on kidney care. By combining Medtronic's healthcare technology expertise with DaVita's extensive experience as a comprehensive kidney care provider, NewCo aims to provide patients with greater access to innovative kidney care products and solutions, including home-based devices. This strategic partnership facilitates the creation of a wide range of kidney care offerings and advancements in dialysis treatments. The partnership structure includes equal equity holdings by Medtronic and DaVita in NewCo, which will be managed by a dedicated management team.
In April 2022, Dialyze Direct acquired Compass Home Dialysis, positioning Dialyze Direct to access new markets and expand its patient base in the end-stage renal disease (ESRD) dialysis sector. This strategic acquisition aims to increase revenue and profitability for Dialyze Direct. Compass Home Dialysis, a specialist in home hemodialysis, aligns with Dialyze Direct's objectives in the evolving landscape of kidney care.
Major companies operating in the hemodialysis market include Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., DaVita Inc., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co. Ltd., Nipro Corporation, NxStage Medical Inc., Cantel Medical Corp., Diaverum, Becton Dickinson And Company, Toray Medical Co. Ltd., Outset Medical Inc., Quanta Dialysis Technologies, Allmed Medical Care Corporation, Rockwell Medical Inc., Medtronic Plc, Gambro AB, Hemoclean Co. Ltd., JMS Co. Ltd., Kawasumi Laboratories Inc., Medcomp, Medline Industries Inc., Merit Medical Systems Inc., Poly Medicure Ltd., Renax Biomedical Tech. Co. Ltd., Teleflex Inc., Terumo Corporation, Thermo Fisher Scientific Inc., W. L. Gore & Associates Inc., Argon Medical Devices Inc., Cook Medical Inc.
North America was the largest region in the hemodialysis market in 2024. Asia-Pacific is expected to be the fastest growing region in the global hemodialysis market report during the forecast period. The regions covered in the hemodialysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hemodialysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Hemodialysis is a medical treatment process that involves the cleansing of blood using a dialyzer, commonly referred to as an artificial kidney, and a dialysis machine. This procedure is employed to filter waste and excess fluids from the blood when the kidneys are no longer able to perform this function adequately.
The primary types of hemodialysis include conventional hemodialysis, short daily hemodialysis or daily hemodialysis, and nocturnal hemodialysis. Conventional hemodialysis is typically conducted three times a week, with each session lasting several hours. Various components utilized in hemodialysis include the dialyzer, dialysis solution, tubes, catheter, and other related materials. These components find application across various end-users, including hospitals, specialty clinics, home-care settings, and others.
The hemodialysis market research report is one of a series of new reports that provides hemodialysis market statistics, including hemodialysis industry global market size, regional shares, competitors with a hemodialysis market share, detailed hemodialysis market segments, market trends and opportunities, and any further data you may need to thrive in the hemodialysis industry. This hemodialysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hemodialysis market includes revenues earned by entities by in-center hemodialysis and peritoneal dialysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The hemodialysis market size is expected to see strong growth in the next few years. It will grow to $125.15 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing healthcare expenditure, telehealth integration in renal care, regulatory support for home hemodialysis, focus on personalized medicine in nephrology, and global health crisis preparedness. Major trends in the forecast period include minimally invasive procedures, technological advancements, patient-friendly devices, integration with imaging and diagnostics, and customized treatment approaches.
The rising incidence of kidney failure is expected to drive the growth of the hemodialysis market in the coming years. Kidney failure is a medical condition characterized by the kidneys' inability to effectively filter waste and excess fluids from the blood. The increase in kidney failure cases is largely attributed to the growing rates of chronic conditions such as diabetes and hypertension, coupled with an aging population and lifestyle factors. Patients with kidney failure rely on hemodialysis to artificially filter and eliminate waste, excess fluids, and toxins from their blood through a machine, compensating for the reduced function of their kidneys. For example, a report published in June 2023 by Nephrology Dialysis Transplantation (NDT), a UK-based journal, projected that the number of individuals with Chronic Kidney Disease (CKD) in the UK will increase by 4% between 2022 and 2032, rising from 8.27 million to 8.61 million. Thus, the growing prevalence of kidney failure is set to boost the hemodialysis market.
The growth of the hemodialysis market is also influenced by the increasing incidence of lifestyle-related diseases, particularly obesity. Lifestyle-related diseases significantly impact an individual's health, playing a pivotal role in the development of chronic kidney disease (CKD), necessitating hemodialysis. The World Health Organization reported in March 2022 that over 1 billion people globally, including 650 million adults, 340 million teenagers, and 39 million children, suffer from obesity, a number continually rising. With lifestyle-related diseases contributing to CKD, the demand for hemodialysis is expected to grow significantly.
The technological advancements are a notable trend, with major companies concentrating on innovative technologies to maintain their market positions. In August 2022, Fresenius Medical Care AG & Co. KGaA introduced Speedswap, an innovative option for the NxStage System One with NxView. This technology allows changing a flow-compromised dialysis filter without replacing the entire cartridge, reducing therapy downtime, nursing workloads, and treatment costs in acute care settings. Technological innovation enhances patient care and operational efficiency in the hemodialysis sector.
A strategic partnership approach is adopted by major companies operating in the hemodialysis market to enhance patient outcomes and treatment experiences. In May 2022, Medtronic Plc announced a partnership with DaVita Inc. to establish a novel, independent medical device business called NewCo, focusing on kidney care. By combining Medtronic's healthcare technology expertise with DaVita's extensive experience as a comprehensive kidney care provider, NewCo aims to provide patients with greater access to innovative kidney care products and solutions, including home-based devices. This strategic partnership facilitates the creation of a wide range of kidney care offerings and advancements in dialysis treatments. The partnership structure includes equal equity holdings by Medtronic and DaVita in NewCo, which will be managed by a dedicated management team.
In April 2022, Dialyze Direct acquired Compass Home Dialysis, positioning Dialyze Direct to access new markets and expand its patient base in the end-stage renal disease (ESRD) dialysis sector. This strategic acquisition aims to increase revenue and profitability for Dialyze Direct. Compass Home Dialysis, a specialist in home hemodialysis, aligns with Dialyze Direct's objectives in the evolving landscape of kidney care.
Major companies operating in the hemodialysis market include Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., DaVita Inc., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co. Ltd., Nipro Corporation, NxStage Medical Inc., Cantel Medical Corp., Diaverum, Becton Dickinson And Company, Toray Medical Co. Ltd., Outset Medical Inc., Quanta Dialysis Technologies, Allmed Medical Care Corporation, Rockwell Medical Inc., Medtronic Plc, Gambro AB, Hemoclean Co. Ltd., JMS Co. Ltd., Kawasumi Laboratories Inc., Medcomp, Medline Industries Inc., Merit Medical Systems Inc., Poly Medicure Ltd., Renax Biomedical Tech. Co. Ltd., Teleflex Inc., Terumo Corporation, Thermo Fisher Scientific Inc., W. L. Gore & Associates Inc., Argon Medical Devices Inc., Cook Medical Inc.
North America was the largest region in the hemodialysis market in 2024. Asia-Pacific is expected to be the fastest growing region in the global hemodialysis market report during the forecast period. The regions covered in the hemodialysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hemodialysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Hemodialysis is a medical treatment process that involves the cleansing of blood using a dialyzer, commonly referred to as an artificial kidney, and a dialysis machine. This procedure is employed to filter waste and excess fluids from the blood when the kidneys are no longer able to perform this function adequately.
The primary types of hemodialysis include conventional hemodialysis, short daily hemodialysis or daily hemodialysis, and nocturnal hemodialysis. Conventional hemodialysis is typically conducted three times a week, with each session lasting several hours. Various components utilized in hemodialysis include the dialyzer, dialysis solution, tubes, catheter, and other related materials. These components find application across various end-users, including hospitals, specialty clinics, home-care settings, and others.
The hemodialysis market research report is one of a series of new reports that provides hemodialysis market statistics, including hemodialysis industry global market size, regional shares, competitors with a hemodialysis market share, detailed hemodialysis market segments, market trends and opportunities, and any further data you may need to thrive in the hemodialysis industry. This hemodialysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hemodialysis market includes revenues earned by entities by in-center hemodialysis and peritoneal dialysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Hemodialysis Market Characteristics3. Hemodialysis Market Trends and Strategies4. Hemodialysis Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market32. Global Hemodialysis Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Hemodialysis Market34. Recent Developments in the Hemodialysis Market
5. Global Hemodialysis Growth Analysis and Strategic Analysis Framework
6. Hemodialysis Market Segmentation
7. Hemodialysis Market Regional and Country Analysis
8. Asia-Pacific Hemodialysis Market
9. China Hemodialysis Market
10. India Hemodialysis Market
11. Japan Hemodialysis Market
12. Australia Hemodialysis Market
13. Indonesia Hemodialysis Market
14. South Korea Hemodialysis Market
15. Western Europe Hemodialysis Market
16. UK Hemodialysis Market
17. Germany Hemodialysis Market
18. France Hemodialysis Market
19. Italy Hemodialysis Market
20. Spain Hemodialysis Market
21. Eastern Europe Hemodialysis Market
22. Russia Hemodialysis Market
23. North America Hemodialysis Market
24. USA Hemodialysis Market
25. Canada Hemodialysis Market
26. South America Hemodialysis Market
27. Brazil Hemodialysis Market
28. Middle East Hemodialysis Market
29. Africa Hemodialysis Market
30. Hemodialysis Market Competitive Landscape and Company Profiles
31. Hemodialysis Market Other Major and Innovative Companies
35. Hemodialysis Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Hemodialysis Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on hemodialysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for hemodialysis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hemodialysis market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Conventional Hemodialysis; Short Daily Hemodialysis or Daily Hemodialysis; Nocturnal Hemodialysis2) By Component: Dialyzer; Dialysis Solution; Tubes; Catheter; Other Components
3) By End User: Hospitals; Specialty Clinics; Home-Care Settings; Other End Users
Subsegments:
1) By Conventional Hemodialysis: In-Center Hemodialysis; Home Hemodialysis2) By Short Daily Hemodialysis: Home-Based Short Daily Hemodialysis; in-Center Short Daily Hemodialysis
3) By Nocturnal Hemodialysis: Home Nocturnal Hemodialysis; in-Center Nocturnal Hemodialysis
Key Companies Mentioned: Asahi Kasei Corporation; B. Braun Melsungen AG; Baxter International Inc.; DaVita Inc.; Fresenius Medical Care AG & Co. KGaA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Asahi Kasei Corporation
- B. Braun Melsungen AG
- Baxter International Inc.
- DaVita Inc.
- Fresenius Medical Care AG & Co. KGaA
- Nikkiso Co. Ltd.
- Nipro Corporation
- NxStage Medical Inc.
- Cantel Medical Corp.
- Diaverum
- Becton Dickinson And Company
- Toray Medical Co. Ltd.
- Outset Medical Inc.
- Quanta Dialysis Technologies
- Allmed Medical Care Corporation
- Rockwell Medical Inc.
- Medtronic Plc
- Gambro AB
- Hemoclean Co. Ltd.
- JMS Co. Ltd.
- Kawasumi Laboratories Inc.
- Medcomp
- Medline Industries Inc.
- Merit Medical Systems Inc.
- Poly Medicure Ltd.
- Renax Biomedical Tech. Co. Ltd.
- Teleflex Inc.
- Terumo Corporation
- Thermo Fisher Scientific Inc.
- W. L. Gore & Associates Inc.
- Argon Medical Devices Inc.
- Cook Medical Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 96.28 Billion |
| Forecasted Market Value ( USD | $ 125.15 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 32 |
